Clinical and pharmacological group: & nbsp

Non-narcotic analgesics, including non-steroidal and other anti-inflammatory drugs

Other non-narcotic analgesics, including non-steroidal and other anti-inflammatory drugs

Included in the formulation
  • Ravederm®
    ointment externally 
    BIOPIN PHARMA, LLC     Russia
  • АТХ:

    S.01.B   Anti-inflammatory drugs

    Pharmacodynamics:

    It causes partial denaturation of mucus proteins or wound exudate. The resulting protein film protects sensitive nerve endings from the action of irritants, reducing pain. In addition, there is a local narrowing of the vessels, their permeability and exudate release decrease, which helps to reduce the inflammatory reaction.

    Pharmacokinetics:

    Not studied.

    Indications:

    Inflammatory diseases of the skin and mucous membranes.

    XII.L20-L30.L25.9   Unspecified contact dermatitis, cause not specified

    XII.L20-L30.L25.8   Unspecified contact dermatitis due to other substances

    XII.L20-L30.L25.5   Unspecified contact dermatitis due to plants other than food

    XII.L20-L30.L25.4   Unspecified contact dermatitis due to food when exposed to skin

    XII.L20-L30.L25.3   Unspecified contact dermatitis due to other chemicals

    XII.L20-L30.L25.2   Unspecified contact dermatitis due to dyes

    XII.L20-L30.L25.1   Unspecified contact dermatitis due to medications in contact with skin

    XII.L20-L30.L25.0   Unspecified contact dermatitis due to cosmetics

    XII.L20-L30.L25   Contact dermatitis, unspecified

    XII.L20-L30.L24.9   Simple irritant contact dermatitis, cause not specified

    XII.L20-L30.L24.8   Simple irritant contact dermatitis due to other substances

    XII.L20-L30.L24.7   Simple irritant contact dermatitis caused by plants other than food

    XII.L20-L30.L24.6   A simple irritant contact dermatitis caused by food products when they come into contact with the skin

    XII.L20-L30.L24.5   Simple irritant contact dermatitis due to other chemicals

    XII.L20-L30.L24.4   A simple irritant contact dermatitis caused by drugs when they come into contact with the skin

    XII.L20-L30.L24.3   Simple irritant contact dermatitis caused by cosmetic means

    XII.L20-L30.L24.2   Simple irritant contact dermatitis due to solvents

    XII.L20-L30.L24.1   Simple irritant contact dermatitis due to oils and lubricants

    XII.L20-L30.L24.0   Simple irritant contact dermatitis due to cleansers

    XII.L20-L30.L24   Simple irritant contact dermatitis

    XII.L20-L30.L23.9   Allergic contact dermatitis, cause not specified

    XII.L20-L30.L23.8   Allergic contact dermatitis due to other substances

    XII.L20-L30.L23.7   Allergic contact dermatitis due to plants other than food

    XII.L20-L30.L23.6   Allergic contact dermatitis caused by food products when they come into contact with the skin

    XII.L20-L30.L23.5   Allergic contact dermatitis due to other chemicals

    XII.L20-L30.L23.4   Allergic contact dermatitis due to dyes

    XII.L20-L30.L23.3   Allergic contact dermatitis caused by drugs when they come into contact with the skin

    XII.L20-L30.L23.2   Allergic contact dermatitis due to cosmetics

    XII.L20-L30.L23.1   Allergic contact dermatitis due to sticky substances

    XII.L20-L30.L23.0   Allergic contact dermatitis due to metals

    XII.L20-L30.L23   Allergic contact dermatitis

    XII.L20-L30.L21.9   Seborrheic dermatitis, unspecified

    XII.L20-L30.L21.8   Other seborrheic dermatitis

    XII.L20-L30.L21.1   Seborrheic children's dermatitis

    XII.L20-L30.L21   Seborrheic dermatitis

    XII.L20-L30.L20.9   Atopic dermatitis, unspecified

    XII.L20-L30.L20.8   Other atopic dermatitis

    XII.L20-L30.L20   Atopic dermatitis

    XII.L20-L30   Dermatitis and eczema

    Contraindications:

    Hypersensitivity, acute and chronic lead intoxication. Pregnancy, breast-feeding.

    Carefully:

    In children, efficacy and safety have not been studied.

    Pregnancy and lactation:

    The category of FDA recommendations is not defined.

    Qualitative controlled studies in animals and humans were not conducted. Do not apply. There is no information on the penetration into breast milk. Do not apply.

    Dosing and Administration:

    Outer in the form of lotions, compresses and syringing (aqueous solution). For douching, 10 ml is dissolved in 200 ml of water.

    Side effects:

    Allergic reactions.

    Overdose:Not described.
    Interaction:Not described.
    Special instructions:

    After applying the solution, the bottle should be immediately covered with a lid (because the drug decomposes under the influence of carbon dioxide of the air).

    Instructions
    Up